L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 6 medicines in this group and its subgroups.
- 6 prescription only (POM)
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
-
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
- L01EC01 vemurafenib 1 medicine
- L01EC02 dabrafenib 3 medicines
- L01EC03 encorafenib 2 medicines
-
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
Active substances in the group
- Dabrafenib 3 medicines
- Encorafenib 2 medicines
- Vemurafenib 1 medicine
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Braftovi 50 mg hard capsules SPC (L01EC03 encorafenib) | Prescription only (POM) |
| Braftovi 75 mg hard capsules SPC (L01EC03 encorafenib) | Prescription only (POM) |
| Finlee 10 mg dispersible tablets SPC (L01EC02 dabrafenib) | Prescription only (POM) |
| Tafinlar 50 mg hard capsules SPC (L01EC02 dabrafenib) | Prescription only (POM) |
| Tafinlar 75 mg hard capsules SPC (L01EC02 dabrafenib) | Prescription only (POM) |
| Zelboraf 240 mg film-coated tablets SPC (L01EC01 vemurafenib) | Prescription only (POM) |
Other groups of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 10 medicines
- L01EF Cyclin-dependent kinase (CDK) inhibitors 13 medicines
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 4 medicines
- L01EJ Janus-associated kinase (JAK) inhibitors 18 medicines
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 12 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01EX Other protein kinase inhibitors 94 medicines
Other names of the ATC group
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EC
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.